During the last session, Regencell Bioscience Holdings Ltd (NASDAQ:RGC)’s traded shares were 1.44 million, with the beta value of the company hitting 2.30. At the end of the trading day, the stock’s price was $17.4, reflecting an intraday loss of -9.89% or -$1.91. The 52-week high for the RGC share is $83.60, that puts it down -380.46 from that peak though still a striking 99.54% gain since the share price plummeted to a 52-week low of $0.08. The company’s market capitalization is $8.60B, and the average intraday trading volume over the past 10 days was 3.56 million shares, and the average trade volume was 3.11 million shares over the past three months.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC) trade information
Regencell Bioscience Holdings Ltd (RGC) registered a -9.89% downside in the last session and has traded in the green over the past 5 sessions. The stock plummet -9.89% in intraday trading to $17.4, hitting a weekly high. The stock’s 5-day price performance is 19.18%, and it has moved by -3.59% in 30 days. Based on these gigs, the overall price performance for the year is 13284.62%. The short interest in Regencell Bioscience Holdings Ltd (NASDAQ:RGC) is 1.05 million shares and it means that shorts have 0.73 day(s) to cover.
An analysis of the company’s performance over the past 5 years shows that the company’s earnings shrunk an estimated -60.65%.
RGC Dividends
Regencell Bioscience Holdings Ltd is due to release its next quarterly earnings in August. However, it is important to remember that the dividend yield ratio is merely an indicator meant to only serve as guidance.
Regencell Bioscience Holdings Ltd (NASDAQ:RGC)’s Major holders
Regencell Bioscience Holdings Ltd insiders own 93.84% of total outstanding shares while institutional holders control 0.07%, with the float percentage being 1.10%. UBS GROUP AG is the largest shareholder of the company, while 7.0 institutions own stock in it. As of 2024-06-30, the company held over 312.0 shares (or 0.0024% of all shares), a total value of $1048.0 in shares.
The next largest institutional holding, with 238.0 shares, is of BLACKROCK INC.’s that is approximately 0.0018% of outstanding shares. At the market price on 2024-06-30, these shares were valued at $800.0.
Data provided on May 31, 2025 indicates that Fidelity Concord Street Trust-Fidelity Nasdaq Composite Index Fund owns about 259.01 shares. This amounts to just over 1.99 percent of the company’s overall shares, with a $4.51 million market value.
